MATTIUZZI, Camilla
 Distribuzione geografica
Continente #
NA - Nord America 6.030
AS - Asia 4.650
EU - Europa 4.012
SA - Sud America 532
AF - Africa 121
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 7
Totale 15.368
Nazione #
US - Stati Uniti d'America 5.916
SG - Singapore 2.222
GB - Regno Unito 1.190
CN - Cina 1.104
HK - Hong Kong 740
RU - Federazione Russa 556
BR - Brasile 469
FR - Francia 448
IT - Italia 415
IE - Irlanda 386
DE - Germania 287
SE - Svezia 245
FI - Finlandia 205
KR - Corea 176
UA - Ucraina 98
IN - India 77
CA - Canada 65
TG - Togo 60
VN - Vietnam 58
TR - Turchia 48
NL - Olanda 44
PK - Pakistan 41
ID - Indonesia 24
MX - Messico 24
ES - Italia 23
BD - Bangladesh 22
JP - Giappone 20
AT - Austria 19
IQ - Iraq 17
IR - Iran 16
AR - Argentina 14
PH - Filippine 14
PL - Polonia 14
MA - Marocco 13
BE - Belgio 12
PE - Perù 12
AU - Australia 11
RO - Romania 11
CH - Svizzera 10
EG - Egitto 9
KE - Kenya 9
BG - Bulgaria 8
CR - Costa Rica 8
DK - Danimarca 8
IL - Israele 8
TH - Thailandia 8
ZA - Sudafrica 8
CL - Cile 7
AE - Emirati Arabi Uniti 6
CO - Colombia 6
CZ - Repubblica Ceca 6
PS - Palestinian Territory 6
TN - Tunisia 6
TW - Taiwan 6
UZ - Uzbekistan 6
BO - Bolivia 5
EC - Ecuador 5
EU - Europa 5
HR - Croazia 5
KZ - Kazakistan 5
LT - Lituania 5
PT - Portogallo 5
PY - Paraguay 5
SA - Arabia Saudita 5
UY - Uruguay 5
MY - Malesia 4
NG - Nigeria 4
NZ - Nuova Zelanda 4
PA - Panama 4
VE - Venezuela 4
AL - Albania 3
AZ - Azerbaigian 3
DO - Repubblica Dominicana 3
JO - Giordania 3
TT - Trinidad e Tobago 3
BZ - Belize 2
CI - Costa d'Avorio 2
CU - Cuba 2
DZ - Algeria 2
GE - Georgia 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
NO - Norvegia 2
NP - Nepal 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BY - Bielorussia 1
CG - Congo 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DJ - Gibuti 1
ET - Etiopia 1
HU - Ungheria 1
JM - Giamaica 1
LB - Libano 1
LU - Lussemburgo 1
LY - Libia 1
ML - Mali 1
NE - Niger 1
Totale 15.360
Città #
Southend 1.015
Singapore 990
Dallas 883
Hong Kong 723
Chandler 685
Jacksonville 561
Woodbridge 536
Dublin 382
Ashburn 337
Beijing 233
Ann Arbor 225
Houston 182
Lawrence 179
Princeton 179
Wilmington 160
The Dalles 142
Kent 104
Jinan 80
Columbus 79
Nanjing 79
Verona 78
New York 65
Shenyang 64
Milan 61
Lomé 60
Sindelfingen 58
Helsinki 54
Seattle 49
Redwood City 47
Hebei 44
Tianjin 43
Fairfield 38
Los Angeles 33
São Paulo 32
Council Bluffs 31
Chicago 28
Jiaxing 28
Changsha 27
Haikou 27
Norwalk 27
Santa Clara 27
Nanchang 26
Montreal 25
Zhengzhou 25
Amsterdam 24
Chennai 24
Munich 24
Lappeenranta 22
Moscow 22
Boardman 21
Washington 21
Guangzhou 19
Taiyuan 19
Lahore 18
Ho Chi Minh City 17
Atlanta 16
London 16
Ningbo 16
San Francisco 16
Hangzhou 15
Tokyo 15
Turku 15
Rio de Janeiro 14
Rome 14
Taizhou 13
Baltimore 12
Boston 12
Brooklyn 12
Dearborn 12
Toronto 12
Warsaw 12
Falls Church 11
Mexico City 11
Nuremberg 11
Phoenix 11
Stockholm 11
Vienna 11
Belo Horizonte 10
Cambridge 10
Charlotte 10
Frankfurt am Main 10
Istanbul 10
Lanzhou 10
Redmond 10
Shanghai 10
Shenzhen 10
Tsuen Wan 10
Campinas 9
Dongguan 9
Florence 9
Hanoi 9
Paris 9
Salvador 9
San Diego 9
Secaucus 9
Baghdad 8
Fortaleza 8
Lima 8
Madrid 8
Nairobi 8
Totale 9.482
Nome #
Resurgence of cardiovascular disease mortality: a global and national infodemiological analysis of leading modifiable risk factors 272
Variabilità preanalitica e Medicina di Laboratorio. 233
C-reactive protein and migraine. Facts or speculations? 163
The impact of the COVID-19 pandemic on diabetes-related mortality 142
Atlante di Mortalità. Azienda ULSS n.1 di Belluno 137
Epidemiologia dei suicidi nel territorio della ULSS 21 (Regione Veneto) nel periodo 1989-1998 125
Laboratory preparedness to face infectious outbreaks. Ebola and beyond. 113
Causes, consequences, detection, and prevention of identification errors in laboratory diagnostics. 112
Critical review and meta-analysis on the combination of heart-type fatty acid binding protein (H-FABP) and troponin for early diagnosis of acute myocardial infarction. 110
Red meat consumption and ischemic heart disease. A systematic literature review. 109
Proposal of a checklist for venous blood collection. 107
Prevention of doping in sports: epidemiological issues and ethical implications 105
Application of the new cholesterol guidelines. 104
Managing the patient identification crisis in healthcare and laboratory medicine 104
Prostate-specific antigen (PSA) isoform p2PSA in prostate cancer screening: systematic review of current evidence and further perspectives. 102
Biological samples transportation by drones: ready for prime time? 102
Critical review and meta-analysis of spurious hemolysis in blood samples collected from intravenous catheters. 100
Meat consumption and cancer risk: a critical review of published meta-analyses 99
Worldwide epidemiology and trends of adenosine diphosphate (ADP) receptor inhibitors usage 97
Testing volume is not synonymous of cost, value and efficacy in laboratory diagnostics. 96
Prostate-Specific Antigen for Prostate Cancer Screening: A Different Strategy Should Be Planned. 95
Alcohol consumption and venous thromboembolism: friend or foe? 95
Laboratory quality improvement by implementation of phlebotomy guidelines. 93
Event reporting in laboratory medicine. Is there something we are missing? 92
Glycogen phosphorylase isoenzyme BB in the diagnosis of acute myocardial infarction: A meta-analysis. 92
Adiponectin and migraine: systematic review of clinical evidence. 92
Current epidemiology of low back pain 92
New guidelines on treatment of blood cholesterol: too much of a good thing? 91
BRCA population screening for predicting breast cancer: for or against? 91
Trends of popularity of cardiac biomarkers: Insights from Google Trends 91
Overview on patient safety in healthcare and laboratory diagnostics. 90
Red meat, processed meat and the risk of venous thromboembolism: Friend or foe? 89
Smoking-related mortality in the United States. 88
Point of care troponin testing: Rules and regulations. 86
Novel and emerging therapies: thrombus-targeted fibrinolysis. 86
Preoperative laboratory testing 85
Biomarker validation in the emergency department. General criteria and clinical implications. 85
Cardiovascular risk factors: updated worldwide population statistics 85
Epidemiologic burden of ischemic heart disease in Italy 85
Mandatory wearing of helmets for elite cyclists: new perspectives in prevention of head injuries. 83
Geographical trend of biomedical research: Analysis of a decade of publications in an "enlarged" Group of Eight (G8). 83
Mean platelet volume in patients with ischemic heart disease: meta-analysis of diagnostic studies. 83
The challenges of evaluating scientists by H-index and citations in different biomedical research platforms. 83
Direct oral anticoagulants: analysis of worldwide use and popularity using Google Trends 83
Cortisol and migraine. A systematic literature review 83
Are we getting better at the preanalytical phase or just better at measuring it? 83
Fried food consumption and ischemic heart disease. A systematic literature review. 83
Worldwide epidemiology of carbon monoxide poisoning 82
Oral anticoagulants around the world: an updated state-of-the art analysis 81
Meat consumption and cancer risk: is the definition of red meat always suitable? 81
Screening for recreational drugs in sports. Balance between fair competition and private life. 81
Pregnancy-associated plasma protein A (PAPP-A) for the early diagnosis of myocardial infarction: more doubts than certainties. 81
Effect of melatonin supplementation on tinnitus: systematic literature review and meta-analysis 80
Circulating microRNAs (miRs) for diagnosing acute myocardial infarction: Meta-analysis of available studies. 80
Thrombophilia testing in patients taking direct oral anticoagulants. Handle with care. 80
E-Cigarettes and Cardiovascular Risk: Beyond Science and Mysticism. 80
Next Generation Antithrombotic Therapy: Focus on Antisense Therapy against Coagulation Factor XI. 80
Scientist impact factor (SIF): a new metric for improving scientists’ evaluation? 80
Gum-chewing and headache: an underestimated trigger of headache pain in migraineurs? 80
A Comparative Evaluation of the Chemiluminescence Immunoassay and ELISA for the Detection of Islet Autoantibodies in Type 1 Diabetes 79
Recenti sviluppi degli esami antidoping. Presupposti giuridici e ricadute pratiche. 79
Severe Acute Respiratory Sindrome (SARS): una nuova ed intrigante sfida diagnostica. 78
The biomarker paradigm: between diagnostic efficiency and clinical efficacy. 78
Anti-doping testing: a moving target? 78
Controlling sources of preanalytical variability in doping samples: challenges and solutions. 77
Combined administration of antibiotics and direct oral anticoagulants: a renewed indication for laboratory monitoring? 76
Is body temperature mass screening a reliable and safe option for preventing COVID-19 spread? 75
Legal regulation and medico-forensic aspects of the current anti-doping legislation. 74
Mean speed in professional cycling: No evidence of decline. 74
The impact of seasonality and other determinants on vitamin D concentration in childhood and adulthood: still an unresolved issue. 73
Measuring the potential impact of physical inactivity on worldwide epidemiology of colorectal and breast cancers 73
MicroRNAs for diagnosing myocardial infarction. Advantages and limitations. 72
Clinical laboratories and infectious outbreak emergencies: Ebola and beyond [I laboratori clinici nell'emergenza dei focolai epidemici infettivi: Ebola e oltre] 72
Stat testing utilization in clinical laboratories. National survey of Italian Society of Clinical Biochemistry and Molecular Biology (SIBioC). 72
Recent updates on worldwide gout epidemiology 72
Cancer statistics: a comparison between World Health Organization (WHO) and Global Burden of Disease (GBD) 72
Concise guide to coronavirus disease 2019 (COVID-19) diagnostics 71
Homocysteine and migraine. A narrative review. 71
Pistorius ineligible for the Olympic Games: the right decision. 70
No Evidence for an Association of Vitamin D Deficiency and Migraine: A Systematic Review of the Literature. 70
No correlation between health care expenditure and mortality in the European Union 70
Superspreaders, asymptomatics and COVID-19 elimination 70
Estimating the worldwide burden of COVID-19 related anosmia and ageusia 69
Are sniffer dogs a reliable approach for diagnosing SARS-CoV-2 infection? 69
Presupposti giuridici e riflessi medico-legali della vigente legislazione antidoping. 69
Meta-analysis of factor V Leiden and prothrombin G20210A polymorphism in migraine. 68
Venous thromboembolism and coffee: critical review and meta-analysis 68
Current Cancer Epidemiology 68
Epidemiological and biological evidence of neutrophil gelatinase-associated lipocalin (NGAL) in cancer. 67
Migraine and erythrocyte biology: a review. 67
Pre-analytical variability and quality of diagnostic testing. Looking at the moon and gazing beyond the finger. 67
Chocolate and migraine: the history of an ambiguous association. 66
Fish Intake and Venous Thromboembolism: A Systematic Literature Review 66
The worldwide burden of smoking‐related oral cancer deaths 66
Biological and epidemiologic updates on lip and oral cavity cancers 66
Nuove realtà in politica sanitaria: benchmarking e laboratorio clinico. 65
Sleep apnea and venous thromboembolism. A systematic review 64
Vegetables intake and venous thromboembolism: a systematic review 64
Scientific publishing in different countries: what simple numbers do not tell 64
Epidemiologic Burden of Red and Processed Meat Intake on Colorectal Cancer Mortality 64
Totale 8.758
Categoria #
all - tutte 68.638
article - articoli 65.239
book - libri 443
conference - conferenze 547
curatela - curatele 0
other - altro 242
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.167
Totale 137.276


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021772 0 0 31 125 161 169 13 45 41 13 128 46
2021/2022929 96 152 7 14 28 33 23 61 84 51 106 274
2022/20232.350 202 92 278 374 227 594 14 156 275 21 79 38
2023/20241.432 60 95 89 133 144 186 130 98 34 85 289 89
2024/20254.902 283 367 354 636 247 107 188 291 705 360 439 925
2025/20262.095 1.078 976 41 0 0 0 0 0 0 0 0 0
Totale 15.841